Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance by Y. Peter Jung et al.
RESEARCH ARTICLE Open Access
Effects of acute ingestion of a pre-workout
dietary supplement with and without
p-synephrine on resting energy
expenditure, cognitive function and
exercise performance
Y. Peter Jung1, Conrad P. Earnest1,2, Majid Koozehchian1, Elfego Galvan1, Ryan Dalton1, Dillon Walker3,
Christopher Rasmussen1, Peter S. Murano4, Mike Greenwood1 and Richard B. Kreider1*
Abstract
Background: The purpose of this study was to examine the effects of acute ingestion of a pre-workout dietary
supplement (PWS) with and without p-synephrine (S) on perceptions of readiness to perform, cognitive function,
exercise performance, and markers of safety.
Methods: In a randomized, double-blind, and counterbalanced manner; 25 healthy and recreationally active male
and female participants ingested a flavored maltodextrin placebo (PLA), a PWS containing beta-alanine (3 g),
creatine nitrate as a salt (2 g), arginine alpha-ketoglutarate (2 g), N-Acetyl-L-Tyrosine (300 mg), caffeine (284 mg),
Mucuna pruiriens extract standardized for 15% L-Dopa (15 mg), Vitamin C as Ascorbic Acid (500 mg), niacin (60 mg),
folate as folic acid (50 mg), and Vitamin B12 as Methylcobalamin (70 mg) with 2 g of maltodextrin and flavoring; or,
the PWS with Citrus aurantium (PWS + S) extract standardized for 30% p-synephrine (20 mg). Participants had heart
rate (HR), blood pressure, resting energy expenditure (REE), 12-lead electrocardiograms (ECG), perceptions about
readiness to perform, cognitive function (Stroop Color-Word test), bench and leg press performance (2 sets of 10
repetitions at 70% of 1RM and 1 set to failure), and Wingate anaerobic capacity (WAC) sprint performance
determined as well as donated blood samples prior to and/or following exercise/supplementation. Data were
analyzed by MANOVA with repeated measures as well as mean changes from baseline with 95% confidence
intervals (CI).
Results: No clinically significant differences were observed among treatments in HR, blood pressure, ECG, or
general clinical blood panels. There was evidence that PWS and PWS + S ingestion promoted greater changes in
REE responses. Participants reported higher perception of optimism about performance and vigor and energy with
PWS and PWS + S ingestion and there was evidence that PWS and PWS + S improved changes in cognitive function
scores from baseline to a greater degree than PLA after 1 or 2 h. However, the scores in the PWS + S treatment did
not exceed PLA or PWS responses at any data point. No statistically significant differences were observed among
treatments in total bench press lifting volume, leg press lifting volume or WAC sprint performance.
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Conclusions: Within the confines of this study, ingestion of PWS and/or PWS + S prior to exercise appears to be
well-tolerated when consumed by young, healthy individuals. The primary effects appear to be to increase REE
responses and improve perceptions about readiness to perform and cognitive function with limited to no effects
on muscular endurance and WAC. The addition of 20 mg of p-synephrine to the PWS provided limited to no
additive benefits.
Trial registration: This trial (NCT02952014) was retrospectively registered on September 13th 2016.
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Background
Research has shown that ingestion of some ergogenic
nutrients and/or caffeinated beverages prior to exercise
can improve mental focus and/or exercise capacity [1, 2].
For this reason, a number of energy drinks and pre-
workout supplements (PWS) have been developed and
marketed to active individuals. The primary ergogenic
properties in most of these supplements appears to be
water, carbohydrate, and caffeine [1]. However, more
recently PWS’s have been developed that not only contain
nutrients that may affect acute exercise performance (e.g.,
carbohydrate, caffeine, nitrates, etc.) but also nutrients
that can increase energy expenditure, reduce catabolism,
and/or promote protein synthesis (e.g., amino acids, creat-
ine, β-alanine, etc.) [1–3]. Theoretically, use of PWS’s
prior to exercise may enhance mental focus, cognitive
function, and/or exercise capacity and regular use of
PWS’s during training may lead to greater training adapta-
tions. Consequently, there has been increased interest in
examining the acute and chronic safety and efficacy of
PWS’s marketed to active individuals as well as whether
adding potentially ergogenic nutrients to PWS’s may
promote additive benefits [1].
This study examined the safety and efficacy of acute
ingestion of a market leading PWS on ratings of percep-
tion of readiness to perform, resting energy expenditure
and metabolism, cognitive function, exercise perform-
ance, and markers of safety. The PWS studied contained
several nutrients at previously reported effective doses
that have ergogenic properties including caffeine [4],
beta-alanine [5], creatine [6], nitrate [7, 8], arginine
alpha-ketoglutarate [9] as well as other nutrients pur-
ported to effect cognitive function like tyrosine [10, 11]
and Mucuna pruriens containing L-Dopa [12, 13]. It is
well established that consuming caffeine prior to exer-
cise (e.g., 3–6 mg/kg) can improve exercise performance,
cognitive function, and vigilance [1, 4]. A number of
studies also indicate that ingestion of nitrate prior to
exercise (e.g., 300 mg) can improve exercise capacity
[7, 8, 14–17]. Theoretically, ingesting these nutrients at
effective doses in PWS’s prior to exercise may improve
perceptions of readiness to perform, cognitive function,
and/or exercise performance leading to higher quality
workouts. If so, regular use of these types of PWS may
effect quality of training and/or training adaptations
particularly if they contain nutrients that have been
reported to enhance training adaptations like beta-
alanine [5, 18–24] and/or creatine [6, 25].
Citrus aurantium is found in the peel of bitter orange
and contains p-synephrine which is a protoalkaloid with
sympathomimetic properties [26–28]. Citrus aurantium
(generally containing 20–100 mg of p-synephrine) has
been purported to serve as a mild central nervous system
stimulant [26, 28], suppress appetite [29], increase resting
energy expenditure and affect carbohydrate and fat
oxidation rates [30–33], and promote weight loss [34–36]
with no negative effects on the cardiovascular system
[37–39]. There is also evidence that Citrus aurantium
ingestion can effect memory [40, 41] and resistance-
exercise performance [30]. Theoretically, adding Citrus
aurantium to a PWS may promote greater resting energy
expenditure, cognitive function, and/or exercise capacity
during an exercise bout. The purpose of this study was to
examine the safety and efficacy of ingesting a market
leading PWS with and without p-synephrine on ratings of
perception of readiness to perform, cognitive function,
resting energy expenditure and metabolism, exercise
performance, and markers of safety. This paper presents
results from a study evaluating the acute effects of PWS
ingestion with and without p-synephrine while the effects
of ingesting these PWS on training adaptations are
presented in a companion paper.
Methods
Research design
This study was conducted in a randomized, double
blind, counter-balanced, and crossover manner. Subjects
participated in a familiarization session and three
treatment testing sessions with a 1-week washout period
observed between each testing session. The study was
conducted at the Exercise & Sport Nutrition Laboratory
(ESNL) at Texas A&M University after obtaining
approval from the university ethics committee. The
following description of methods and procedures pro-
vides an overview of the study.
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Participant recruitment and familiarization
Participants were recruited to participate in this study
from local advertisements. Inclusion criteria required
that each participant have at least 6 months of resistance
training experience immediately prior to entering the
study inclusive of performing bench press and leg press
or squat exercises. Participants were excluded if they
noted a history of treatment for metabolic disease,
hypertension, thyroid disease, arrhythmias, cardiovascu-
lar disease; and/or, if they were currently using any
prescription medication. Further exclusion criteria also
included an intolerance to caffeine and/or other natural
stimulants; pregnant or lactating women; a history of
smoking; and, excessive alcohol consumption (>12
drinks/wk).
Figure 1 presents a CONSORT schematic of enroll-
ment and treatment allocation to the study. A total of
69 individuals responded to advertisements. Of these, a
total of 42 individuals met initial study entry criteria via
phone interview and were invited to a familiarization
session where the details of the study were explained,
informed consent was obtained in compliance with our
Institutional Review Board, medical history was assessed,
and a general medical exam was performed. Height,
weight, and body composition was determined. Partici-
pants then had one repetition maximum (1 RM) bench
press and 1RM leg press determined. Participants also
practiced the anaerobic sprint test used in the study. A
total of 26 individuals began the study. One participant
withdrew due to not feeling comfortable with donating
blood samples after the first testing session. A total
of 25 individuals participated in the study.
Testing sequence
Figure 2 shows the timeline of testing procedures. Prior
to each testing session, participants were instructed to
refrain from exercise, caffeine, and supplements and/or
medications containing stimulants for 48 h prior to test-
ing. Participants were asked to present to the lab after a
12 h fast. Once arriving to the lab, participants donated
~ 20 ml of blood via venipuncture of an antecubital vein
using standard procedures. Following blood sampling,
Fig. 1 CONSORT schematic of enrollment and treatment allocation to the study
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participants completed a readiness to perform (RTP) visual
analogue scale (VAS) and completed a Stroop Color-Word
cognitive function test. Participants were then placed on an
exam table in the supine position while electrodes were
placed on the participant. The metabolic cart was then cali-
brated. After at least 10 min of rest in the supine position;
resting heart rate, blood pressure, and 12 lead electrocar-
diographs (ECG) were obtained. Following this procedure,
resting energy expenditure (REE) measurements were ob-
tained for 10 min.
Participants were then randomly given in a counterba-
lanced and double-blinded manner either one serving
(12 g) of a flavored maltodextrin placebo (PLA); a PWS
containing β-alanine (3 g), creatine nitrate as a salt (2 g),
arginine alpha-ketoglutarate (2 g), N-Acetyl-L-Tyrosine
(300 mg), caffeine (284 mg), Mucuna pruiriens extract
standardized for 15% L-Dopa (15 mg), Vitamin C as As-
corbic Acid (500 mg), niacin (60 mg), folate as folic acid
(50 mg), and Vitamin B12 as Methylcobalamin (70 mg)
with the remainder of the supplement consisting of
flavored maltodextrin to equal 12 g (Nutrabolt Inc.,
Brayan, TX); or, (3) the PWS with Citrus aurantium
(PWS + S) extract standardized for 30% p-synephrine
(20 mg) (Nutratech Inc., Caldwell, NJ). Supplements
were independently packaged by an independent third
party into coded single foil packets for double-blind
administration following Good Manufacturing Practices
and certified to contain the aforementioned ingredients
by VMI Nutrition (Salt Lake City, UT). The contents of
the supplement packets were mixed into approximately
235 ml of water.
After the participant ingested the supplement; supine
heart rate, blood pressure, and ECG’s were obtained
every 10-min during a 30-min REE test. Following REE
assessment and approximately 1 h after ingestion of the
supplements, participants donated a post-supplementation
/ pre-exercise blood sample and had RTP-VAS and Stroop
cognitive function determined. Participants then performed
a 2 min warm up followed by performing 3 sets of 10 repe-
titions at 70% of 1 RM on the bench press interspersed by
2 min rest between sets. During the third set, participants
were asked to complete as many repetitions as possible to
failure. Participants then rested for 5 min, warmed up for
2 min, and then performed 2 sets of 10 repetitions and 1
set to failure at 70% of 1RM on the leg press following simi-
lar procedures. Following a 5 min recovery, participants
then performed a 30 s WAC on a cycle ergometer. Partici-
pants then had post-exercise RTP-VAS and Stroop cogni-
tive function determined and donated a final blood sample
2 h after ingestion of the supplements. The experiment was
repeated using the alternate supplement administered in a
counterbalanced manner two additional times following a
1 week washout after each additional testing session.
Procedures
Body composition
Body mass and height were determined according to
standard procedures using a Healthometer Professional
500KL (Pelstar LLC, Alsip, IL, USA) self-calibrating
digital scale with an accuracy of ± 0.02 kg. Whole body
composition measures (excluding cranium) were deter-
mined with a Hologic Discovery W Dual-Energy X-ray
Absorptiometer (DEXA; Hologic Inc., Waltham, MA,
USA) equipped with APEX Software (APEX Corporation
Software, Pittsburg, PA, USA) by using procedures
previously described [42].
Muscular strength and endurance
Bench press tests were performed using a standard
isotonic Olympic bench press (Nebula Fitness, Versailles,
Fig. 2 Study timeline
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OH) while leg press was determined using a hip/leg sled
(Nebula Fitness, Versailles, OH) using standard proce-
dures [43]. Bench press and leg press 1RM’s were deter-
mined during the familiarization session by having the
participants follow a standard warm-up consisting of 10
repetitions using 50% of their estimated 1RM, 5 repeti-
tions using 70% of their estimated 1RM, and 1 repetition
using 90% of their estimated 1RM. Participants were
given 2 min recovery between attempts and performed
1RM lifts until reaching a failure weight. After 5 min re-
covery, participants warmed-up in a similar fashion as
described above and then performed 1RM lift attempts
on a standard hip sled/leg press (Nebula Fitness, Ver-
sailles, OH) according to standard procedures [43]. For 1
RM determination, strong verbal encouragement was
provided. Hand, seat, and foot placement positions were
recorded to standardize positions among testing ses-
sions. During the muscular endurance test, participants
were asked to perform 2 sets of 10 repetitions at 70% of
1RM, if possible, with 2-min rest between sets. During
the final set, participants were asked to complete as
many repetitions as possible until failure. Total lifting
volume was calculated by multiplying the amount of
weight lifted times the number of successful repetitions
completed during each set. Day to day test reliability of
performing this endurance test in our lab on resistance-
trained participants has yielded a standard error of
measurement (SEM) of 92 kg, a SEM as a percent of
grand mean of 4.1%, a CV of 0.34, and an intraclass cor-
relation coefficient of 0.99 for 3 sets of bench press total
lifting volume; and, a SEM of 820 kg, an SEM as a per-
cent of grand mean of 6.4%, a CV of 0.32, and an intra-
class correlation coefficient of 0.96 for 3 sets of leg press
total lifting volume.
Cardiovascular markers
Heart rate was determined by palpation of the radial ar-
tery while blood pressure was determined using standard
auscultatory procedures [44]. Resting 12-lead ECG’s
were obtained using a Nasiff Cardio Card electrocardio-
graph (Nasiff Associates, Inc, Central Square, NY, USA).
Resting energy expenditure
REE assessments were conducted according to standard
protocols using a metabolic cart (Parvo Medics TrueMax
2400 Metabolic Measurement System, ParvoMedics, Inc,
Sandy, UT, USA). This test was conducted in a fasted
state with the participants lying supine on an exam table.
A clear metabolic canopy was placed over the partici-
pant’s head and neck, so that resting ventilation, oxygen
uptake (VO2), and carbon dioxide (VCO2) measure-
ments could be determined. The participants remained
motionless without falling asleep for approximately
10 min before supplementation and then about 30 min
after supplementation. Metabolic measurements were
recorded every minute over the testing period.
Readiness to perform assessment
Ratings of perceptions of readiness to perform were
assessed using a visual analogue scale using a 5-item de-
scriptive scale (strongly disagree, disagree, neutral, agree,
strongly agree) arranged on a 20 cm dotted bar with
these terms equidistant along the scale. Participants were
asked to respond to the following statements: “I am
looking forward to today’s workout”; “I am optimistic
about my future performance”; “I feel vigorous and ener-
getic”; and, “I have little muscle soreness” by circling the
number or dot between numbers that best described
their current perceptions related to these questions. Day
to day test reliability of administering this test in our lab
has yielded SEM’s of 0.35, 0.25, 0.28, 0.72; SEM as a per-
cent of grand mean of 9.6%, 7.1%, 8.6%, 20.9%; CV’s of
0.23, 0.19, 0.26, and 0.34; and intraclass correlation coef-
ficients of 0.83, 0.86, 0.89, and 0.63 for questions 1
through 4, respectively.
Cognitive function assessment
Cognitive function was assessed using the Stroop Word-
Color test [45, 46] which has widely-used and validated
in a variety of populations [46–50]. The test consists of
three separate pages / tests with 100 items, presented in
5 columns of 20 items. Items on the first page (Word)
are the color words RED, GREEN, and BLUE in black
ink. On the second page (Color) the items are XXX’s
colored in red, green, or blue ink. Items on the third
page (Word-Color) are the words RED, GREEN, and
BLUE printed in red, green, or blue ink with the limita-
tion that word and ink could not match. Participants
were given standardized instructions and asked to read
aloud each word or color on each page as fast as they
could for 45-s on page/test. The number of correct re-
sponses obtained during the time period is used to as-
sess cognitive function. Day to day test reliability of
administering this test in our lab has yielded a SEM’s of
4.9, 9.1, and 10.4 counts; an SEM as a percent of grand
mean of 4.3, 10.5 and 16.7%; CV’s of 0.14, 0.19, and 0.25;
and, intraclass correlation coefficients of 0.90, 0.68, 0.57
for Word, Color and Word-Color, respectively.
Anaerobic capacity test
Wingate anaerobic capacity sprint tests were performed
on a Lode Excalibur Sport Ergometer (Lode Excalibur
Sport Ergometer, Lode BV, Groningen, Netherlands) with
work rate set at of 7.5 J•kg−1•rev−1. Participants were
asked to pedal as fast as possible prior to application of
the workload and sprint at an all-out maximal capacity
for 30 s. Day to day variability in performing Wingate
anaerobic capacity tests in our laboratory yielded an
Jung et al. Journal of the International Society of Sports Nutrition  (2017) 14:3 Page 5 of 15
SEM of 53 W, an SEM as a percent of grand mean of
8.9%, a CV 0.26, and an intraclass correlation coefficient
of 0.89 for mean power.
Blood chemistry assessment
Plasma creatine was assayed prior to and after 1 and 2 h
of supplementation as a general indicator of supplement
bioavailability using calorimetric assay kits (Sigma-Al-
drich, St. Louis, MO), Test-to-test variability of perform-
ing these assays yielded a SE of 0.09, an SEM as a
percent of grand mean of 6%, mean CV of ± 0.1, and an
intraclass correlation coefficient of 0.99. Serum alkaline
phosphatase (ALP), aspartate transaminase (AST), ala-
nine transaminase (ALT), creatine kinase (CK), lactate
dehydrogenase (LDH), blood urea nitrogen (BUN), cre-
atinine, total cholesterol (CHL), high density lipoprotein
[HDL-c], low density lipoprotein [LDL-c], triglycerides
[TG]), and glucose were assayed using a Cobas c 111
(Roche Diagnostics, Basel, Switzerland) prior to and fol-
lowing 2 h after supplementation. This analyzer has been
known to be highly valid and reliable in previously pub-
lished reports [51]. The internal quality control was per-
formed using two levels of control fluids purchased from
the manufacturer to calibrate to acceptable standard de-
viations (SD’s) and CV’s. Samples were re-run if the ob-
served values were outside control values and/or clinical
norms according to standard procedures. Test-to-test re-
liability (10-days) assessment yielded reliability CV’s ran-
ging between 0.4 and 2.4% for low control samples and
0.6–1.9% for high controls with precision ranging be-
tween 0.8 and 2.4% on low and 0.5–1.7% for high
controls.
Statistical analysis
Data were analyzed using general linear models (GLM)
multivariate analysis of variance (MANOVA) with Wilks’
Lambda and Greenhouse-Geisser adjustments using
SPSS version 22.0 software (IBM SPSS Statistics, Chi-
cago, IL). When a significant treatment, time and/or
interaction alpha level was observed, Tukey’s least sig-
nificant difference post-hoc analysis was performed to
determine where significance was obtained. Area under
the curve (AUC) was calculated on select variables using
GraphPad Prism 6 software (GraphPad Software, Inc.,
La Jolla, CA). Delta values were calculated from sub-
tracting baseline values with means and 95% Confidence
Interval (CI) to determine whether changes from base-
line and/or among treatments were significant [52].
Means were considered significantly different when the
probability of error was 0.05 or less with statistical ten-
dencies and effect size calculations noted when p-levels
ranged between p > 0.05 to p < 0.10. All data are pre-
sented as mean ± SD unless otherwise noted.
Results
Participant demographics
Table 1 presents participant demographics. A total of 25
individuals completed the study (20 males and 5 fe-
males). Participants were 22 ± 3 y, 176.1 ± 8.2 cm, 78.2 ±
13.0 kg, 15.2 ± 5.2% fat, and 25.09 ± 3.0 kg/m2. No par-
ticipant experienced an adverse medical event as result
of participation in this study that required medical treat-
ment or any abnormal clinical findings that required
medical referral.
Cardiovascular markers
Table 2 shows HR, systolic blood pressure (SBP), and
diastolic blood pressure (DBP) responses observed
among treatments. No significant treatment x time inter-
actions were observed in HR, SBP, or DBP responses ob-
tained prior to and during the REE test. Additionally, no
noticeable changes were observed in resting 12-lead
ECG recordings.
Resting energy expenditure
Figure 3 presents oxygen uptake (VO2), carbon dioxide
production (VCO2), and respiratory exchange ratio
(RER) values (VCO2/VO2) observed during the post-
supplementation REE test. MANOVA revealed an over-
all significant Wilks’ Lambda treatments x time effect (p
< 0.001) as well as significant univariate ANOVA treat-
ments x time interactions VCO2 (p = 0.008) and RER
values (p = 0.001). Post-hoc analysis revealed that PWS
and PWS + S ingestion primarily effected VCO2 and
RER responses compared to the PLA treatment and that
PWS ingestion promoted higher VCO2 and RER values
toward the end of the 30 min REE test. Analysis of AUC
changes from baseline revealed significant differences
among treatments in VO2 (PLA 684 ± 376; PWS 802 ±
434; PWS + S 1,034 ± 584 ml/min, p = 0.015), VCO2
(PLA 634 ± 262; PWS 1,151 ± 673; PWS + S 1,372 ±
604 ml/min, p < 0.001), and RER (PLA 1.48 ± 0.67; PWS
2.44 ± 0.98; PWS + S 2.79 ± 0.89, p < 0.001). Post-hoc
analysis revealed that VO2 AUC in the PWS + S treat-
ment was significantly greater than the PLA treatment
(p = 0.013, CI [64, 636]) but not the PWS treatment.
VCO2 and RER AUC values were significantly higher in
the PWS (VCO2 p < 0.001, CI [242, 792]; RER p < 0.001,
CI [−.43, −1.53]) and PWS + S (VCO2 p < 0.001, CI
[−1,036, −440]; RER p < 0.001, CI [−1.87, −0.78]) com-
pared to the PLA treatment. However, no significant
differences were observed between PWS and PWS + S
treatments.
Perceptions of readiness to perform
Perceptions about readiness to perform are presented in
Table 3. MANOVA revealed a significant overall Wilks’
Lambda treatments x time interaction (p = 0.004) in
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perceptions of readiness to perform questions. Signifi-
cant univariate ANOVA treatments x time effects were
also observed in response to “I am optimistic about my
future performance” and “I feel vigorous and energetic”.
Post-hoc analysis revealed that participants in the PWS
and PWS + S treatments rated optimism about perform-
ance and feelings of vigor and energy higher than the
PLA treatment after 1 h of ingestion. However, percep-
tions about optimism about performance and vigor and
energy in the PWS + S treatment were lower than PLA
and PWS responses after 2 h. No significant treatments
x time interactions were seen in remaining questions.
Cognitive function
Table 4 presents Stroop Color-Word cognitive function
results. An overall Wilk’s Lambda treatments x time
interaction effect was observed among treatments (p <
0.001). Significant univariate ANOVA treatment x time
interactions were also observed in Word, Color and
Word-Color scores. Post-hoc analysis revealed that
Word, Color and Word-Color scores significantly in-
creased over time in the PWS and/or PWS + S treat-
ments with values in the PWS and PWS + S treatments
significantly greater than the PLA at several data points.
Figure 4 presents changes from baseline with 95% CI
values. These graphs show that changes in Word, Color,
and Word-Color were significantly increased above
baseline (i.e., mean and 95% CI above baseline) more
consistently in the PWS and/or PWS + S treatments
compared to the PLA treatment. Additionally, changes
in the PWS and/or PWS + S were significantly greater
than PLA responses at several data points. There was
also some evidence that changes in the PWS + S treat-
ment were significantly greater than the PWS treatment
at several data points. However, it should be noted that
pre-supplementation values in the PWS + S treatment
were lower at baseline compared to PLA and PWS re-
sponses so these data should be interpreted with
caution.
Performance assessment
Table 5 shows bench press and leg press lifting volume
observed during the 3rd set to failure and for all three
sets of exercise while Table 6 presents Wingate anaer-
obic sprint capacity results. All participants completed
10 repetitions during the first set. One of participants
was only able to complete 7 repetitions during the sec-
ond set but this was consisted in each trial. MANOVA
revealed tendencies toward significant differences among
treatments in bench press 3rd set lifting volume (p =
0.086, partial η2 = 0.08) and total lifting volume (p = 0.10,
partial η2 = 0.08). Lifting volume for the 3rd set to failure
also tended to be greater in the PWS + S compared to
the PLA treatment (p = 0.057, partial η2 = 0.09, Cohen’s
D = 0.18). No significant differences were observed in leg
Table 1 Participant Demographics
N Age Height BMI Body Weight Fat-Free Mass Body Fat
(y) (cm) (kg/m2) (kg) (kg) (%)
Overall 25 21.7 ± 3.0 176.1 ± 8.2 25.0 ± 3.0 78.2 ± 13.0 61.0 ± 11.6 15.2 ± 5.2
Male 20 21.4 ± 2.7 178.9 ± 5.9 25.9 ± 2.4 83.0 ± 8.5 65.5 ± 7.2 14.0 ± 4.8
Female 5 23.2 ± 3.1 164.8 ± 5.4 21.7 ± 2.4 59.3 ± 8.5 42.9 ± 5.9 20.1 ± 3.2
Data are means ± standard deviations
Table 2 Heart Rate and Blood Pressure Response
Variable Treatment Time (min) p-
levelPre 0 10 20 30
HR (beats/min) PLA 58.2 ± 9.5 60.4 ± 8.1 58.6 ± 8.5 59.6 ± 8.3 60.6 ± 8.4 0.84
PWS 55.5 ± 7.3 58.2 ± 9.5 54.2 ± 7.2 56.5 ± 7.7 58.1 ± 8.1
PWS + S 56.6 ± 7.2 57.5 ± 8.8 56.5 ± 9.5 58.4 ± 9.1 60.4 ± 10.8
SBP (mmHg) PLA 113.3 ± 7.6 114.3 ± 8.0 112.7 ± 6.8 114.3 ± 6.3 113.6 ± 6.6 0.52
PWS 111.5 ± 7.1 112.4 ± 7.3 112.9 ± 8.6 112.8 ± 7.9 112.5 ± 8.2
PWS + S 113.1 ± 7.8 112.5 ± 8.3 113.0 ± 9.6 113.9 ± 10.6 114.6 ± 10.0
DBP (mmHg) PLA 69.6 ± 6.8 69.2 ± 6.5 68.8 ± 6.3 69.5 ± 7.4 69.1 ± 7.1 0.51
PWS 69.0 ± 6.7 70.7 ± 6.1 70.9 ± 7.1 70.6 ± 7.5 70.4 ± 7.7
PWS + S 69.6 ± 7.2 70.0 ± 6.7 71.0 ± 6.8 71.1 ± 8.1 68.4 ± 13.0
Data are means ± standard deviations for Heart Rate (HR), Systolic Blood Pressure (SBP), and Diastolic Blood Pressure (DBP). MANOVA analysis revealed overall
Wilks’ Lambda treatment (p = 0.28), time (p = 0.03), and treatment x time (p = 0.81). Greenhouse-Geisser univariate p-levels of interactions (treatment x time) are
reported above
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press or cycling sprint peak power, mean power, or total
work.
Blood chemistry
Table 7 presents plasma creatine values observed in re-
sponse to supplementation treatments. Results revealed
that PWS and PWS + S ingestion significantly increased
plasma creatine levels after 1 h and 2 h in comparison to
the PLA treatment. Tables 8 and 9 present pre- and 2 h
post supplementation/exercise blood chemistry panels.
No significant interactions were observed among
treatments in ALP, ALT, AST, CK, or LDH. Significant
interactions were observed among treatments in BUN,
creatinine, and BUN to creatinine ratio. As expected,
PWS and PWS + S supplementation (which contained
about 1.3 g of creatine) resulted in a small increase in
creatinine in which values were well-within normal
limits for active individuals [53, 54]. BUN and the BUN
to creatinine ratio decreased indicative of less whole
body catabolism. No significant interactions were
observed among treatments in HDL-C, LDL-C or trigly-
ceride levels. Significant treatments x time effects were
observed in total cholesterol, the ratio of CHOL: HDL
and blood glucose levels. However, given that partici-
pants ingested caffeine with a small amount of malto-
dextrin prior to exercise, these changes were expected
and within normal expected values for trained individ-
uals undergoing intense exercise [53–56] as well as
within normal clinical ranges [57].
Discussion
The purpose of this study was to examine the effects of
acute ingestion of a PWS with and without p-synephrine
on resting energy expenditure, perceptions of readiness
to perform, cognitive function, and anaerobic exercise
performance. Additionally, to examine the safety of
acute ingestion of these PWS’s on resting heart rate,
blood pressure, 12-lead ECG tracings, and standard
clinical blood chemistry panels. Results revealed that
ingestion of these PWS’s did not promote clinically
Fig. 3 Oxygen update (Panel a), carbon dioxide production (Panel b), and respiratory exchange ratio values (Panel c) observed during the first
30-min following supplementation. Data are mean ± SD. ^ represents p < 0.05 difference between PLA and PWS; + represents p < 0.05 difference
between PLA and PWS + S; and, * represents p < 0.05 difference between PWS and PWS + S
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significant changes in heart rate, blood pressure, ECG
findings, or clinical blood markers. Thus, acute ingestion
of these PWS’s prior to exercise appeared to be well-
tolerated when consumed by young, healthy individuals.
The primary effect of ingesting these PWS’s prior to
exercise appeared to be an increase resting energy expend-
iture, improved perceptions about readiness to perform,
and improved cognitive function. There were limited to no
effects on bench press and leg press muscular endur-
ance as well as anaerobic sprint capacity. Moreover,
Fig. 4 Changes in Stroop Word (Panel a), Color (Panel b), and Word-Color (Panel c) counts. Data are mean change and 95% CI. * represents
p < 0.05 difference from baseline, a = p < 0.05 from PLA, b = p < 0.05 from PWS, c = p < 0.05 difference from PWS + S. † represents p > 0.05 to
p < 0.10 difference
Table 3 Readiness to Perform Visual Analogue Scale
Questions Treatment Time (h) p-level
Pre 1 2
I am looking forward to today’s workout PLA 3.67 ± 0.85 3.61 ± 1.00 3.61 ± 0.87 0.21
PWS 3.71 ± 0.77 3.89 ± 0.79 3.65 ± 0.65
PWS + S 3.71 ± 0.99 3.82 ± 1.17 3.51 ± 1.09
I am optimistic about my future performance PLA 3.74 ± 0.83 3.70 ± 0.94 3.78 ± 0.88 0.02q
PWS 3.88 ± 0.69 4.05 ± 0.73 a 3.83 ± 0.70
PWS + S 4.00 ± 0.69 4.21 ± 0.62 a 4.01 ± 0.71
I feel vigorous and energetic PLA 3.23 ± 0.95 3.35 ± 0.90 3.38 ± 1.04 0.001
PWS 3.19 ± 0.89 3.77 ± 0.78 *a 3.33 ± 1.09
PWS + S 3.33 ± 0.77 3.89 ± 0.73 *a 2.96 ± 0.97 a,b
I have little muscle soreness PLA 3.60 ± 0.99 3.42 ± 0.99 3.29 ± 1.01 0.17
PWS 3.54 ± 1.17 3.81 ± 1.35 3.25 ± 1.03
PWS + S 3.13 ± 1.31 3.27 ± 1.28 3.21 ± 1.12
Values are means ± standard deviations. MANOVA analysis revealed overall Wilks’ Lambda treatment (p = 0.03), time (p = 0.01), and treatment x time (p = 0.004).
Greenhouse-Geisser linear or quadratic (q) univariate p-levels of interactions (treatment x time) are reported above * represents p < 0.05 difference from baseline.
a denotes a significant difference from PLA. b denotes a significant difference from PWS. c denotes a significant difference from PWS + S
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adding 20 mg of p-synephrine to the PWS provided
little to no additive benefits. The following sections
provide a more detailed analysis of results observed
and comparison to available literature.
Resting energy expenditure
A number of studies have reported that ingestion of
energy drinks and/or thermogenic type supplements
primarily containing caffeine can increase resting metab-
olism [58–65]. For example, Taylor and colleagues [65]
reported that ingestion of caffeine enriched coffee
(400 mg) increased REE by approximately 14% for up to
3-h compared to consumption of coffee containing
standard amounts of caffeine (200 mg). Rudelle and
coworkers [66] reported that consuming beverages
containing green tea catechins, caffeine, and calcium for
3-days increased energy expenditure by 106 ± 31 kcal/
24 h. Ryan et al. [62] reported that ingestion of a
thermogenic supplement containing caffeine, capsaicin,
bioperine, and niacin increased energy expenditure and
oxygen update values. Wilborn and associates [64] re-
ported that ingestion of a thermogenic supplement
containing green tea extract and caffeine increased REE
by 15-19% compared to 0.3–2.5% when ingesting a
placebo. Campbell and coworkers [60] reported that
ingestion of a supplement containing 200 mg of caffeine
and green tea extract significantly increased resting
metabolic rate from 7 to 9% for up to 3 h after ingestion.
Moreover, Miles-Chan and colleagues [67] reported that
consumption of a sugar free energy drink containing 120 mg
of caffeine increased REE by about 4% and that the changes
observed were due to the caffeine in the drinks rather than
other nutrients (i.e., taurine and glucuronolactone).
Citrus aurantium (generally containing 20–100 mg of
p-synephrine) has also been purported to increase rest-
ing energy expenditure and/or effect carbohydrate and
fat oxidation rates [30–33]. For example, Ratamass and
colleagues [31] reported that ingestion of 100 mg of
p-synephrine increased lipolysis primarily at rest as well
as post-exercise oxygen uptake, energy expenditure, and
fat oxidation. Sale et al. [33] reported that ingesting a
supplement containing 6 mg of p-synephrine, 150 mg
caffeine, and 150 mg catechin polyphenols increased
resting and exercise carbohydrate oxidation rates.
Additionally, Gutiérrz-Hellín and Del Coso [32] reported
that acute p-synephrine ingestion (3 mg/kg) increased
fat oxidation rates while exercising at low-to-moderate
exercise intensities. Thus, there is support to the ration-
ale that adding p-synephrine to a PWS can increase
metabolism and affect substrate utilization.
Results of the present study provide some support to
this contention. In this regard, mean oxygen uptake
during the 30 min REE test was increased by about 1.4%
Table 4 Stroop Word-Color Test
Variable Treatment Time (h) p-level
Pre 1 2
Word (counts) PLA 120.9 ± 15.7 121.1 ± 16.6 122.6 ± 18.0 <0.001
PWS 116.7 ± 15.5 a 119.5 ± 15.4 124.6 ± 17.7 *
PWS + S 104.8 ± 11.4 a,b 115.0 ± 13.6 *a,c 116.8 ± 14.4 *a,b
Color (counts) PLA 89.9 ± 12.4 90.2 ± 13.6 93.8 ± 17.1 0.02
PWS 91.2 ± 21.3 95.1 ± 19.9 99.4 ± 21.0 *c
PWS + S 79.7 ± 10.5 a,b 84.9 ± 11.7 a,b 89.8 ± 12.5 *b
Word-Color (counts) PLA 66.4 ± 9.6 66.8 ± 14.9 71.3 ± 11.7 0.037
PWS 67.5 ± 20.3 70.2 ± 21.6 74.6 ± 18.9 *
PWS + S 52.4 ± 10.6 a,b 57.0 ± 10.4 a,b 64.0 ± 10.8 *a,b
Values are means ± standard deviations for Stroop Word, Color, and Word-Color tests. MANOVA analysis revealed overall Wilks’ Lambda treatment (p < 0.001), time
(p < 0.001), and treatment x time (p < 0.001). Greenhouse-Geisser univariate p-levels of interaction (treatment x time) are reported above. * represents p < 0.05
difference from baseline. a denotes a significant difference from PLA. b denotes a significant difference from PWS. c denotes a significant difference from PWS + S
Table 5 Bench Press and Leg Press Endurance
Variable Treatment Total Volume p-level
Bench Press 3rd Set
Lifting Volume (kg)
PLA 879 ± 440 0.086
PWS 933 ± 460
PWS + S 962 ± 500 a
Leg Press 3rd Set Lifting
Volume (kg)
PLA 6,712 ± 3,538 0.29
PWS 7,295 ± 3,589
PWS + S 6,825 ± 3016
Bench Press Total Lifting
Volume (kg)
PLA 2,166 ± 718 0.10
PWS 2,217 ± 732
PWS + S 2,268 ± 809
Leg Press Total Lifting
Volume (kg)
PLA 12,550 ± 4,321 0.30
PWS 13,139 ± 4,409
PWS + S 12,701 ± 3,866
Values are means ± standard deviations. MANOVA analysis revealed overall
Wilks’ Lambda of p = 0.098 for 3rd set lifting volume and p = 0.117 for total
lifting volume. Greenhouse-Geisser univariate p-levels are presented above. a
represents p < 0.057 difference from PLA. c represents p < 0.057 difference
from PWS + S
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in the PLA treatment compared to 5.6% in the PWS
treatment and 8.6% in the PWS + S treatment. There
was also evidence that PWS and PWS + S ingestion
significantly increased resting VCO2 and RER to a
greater degree than in the PLA treatment indicating
greater carbohydrate oxidation. Analysis of AUC
changes from baseline indicated that while PWS had a
greater impact on VO2 VCO2 and RER values; the PWS
+ S observed greater changes from baseline compared to
the PLA treatment. These findings are consistent with
several reports indicating that ingestion of thermogenic
type supplements increases energy metabolism and/or
carbohydrate oxidation [33, 62, 66, 67] while contrasting
other studies reporting either no effects [64] or greater
fat oxidation [32]. However, ingestion of PWS + S
treatment did not result in higher mean VO2 values than
the PWS treatment. Therefore, the addition of p-
synephrine to the PWS did not promote greater overall
energy expenditure. Whether adding higher levels of
p-synephrine would promote added benefits remains to
be determined.
Perceptions of readiness to perform and cognitive
function
Numerous studies indicate that ingesting caffeine
containing energy drinks or supplements can improve
mental focus and/or cognition [1, 4, 68–70]. There is
Table 6 Wingate Anaerobic Capacity Test
Variable Treatment Value p-level
Peak Power (Watt) PLA 1,578 ± 510 0.46
PWS 1,502 ± 561
PWS + S 1,491 ± 515
Mean Power (Watt) PLA 602 ± 131 0.61
PWS 595 ± 145
PWS + S 582 ± 188
Peak Power (Watt/kg) PLA 19.8 ± 5.1 0.51
PWS 19.0 ± 5.2
PWS + S 18.8 ± 5.2
Mean Power (Watt/kg) PLA 7.6 ± 1.0 0.78
PWS 7.6 ± 1.2
PWS + S 7.7 ± 1.3
Total Work (Joules) PLA 17,662 ± 4,605 0.49
PWS 17,850 ± 4,340
PWS + S 18,203 ± 4,658
Values are means ± standard deviations. MANOVA analysis revealed overall
Wilks’ Lambda group (p = 0.89). Greenhouse-Geisser univariate p-levels are
reported above
Table 7 Plasma Creatine
Variable Treatment Time (h) p-level
0 1 2
Plasma Creatine PLA 0.74 ± 0.27 0.69 ± 0.21 0.71 ± 0.24 <0.001
(μmol/L) PWS 0.71 ± 0.19 3.13 ± 1.43 *a 3.10 ± 1.45 *a
PWS + S 0.68 ± 0.17 3.28 ± 1.13 *a 3.89 ± 1.61 *a,b
Values are means ± standard deviations. MANOVA analysis revealed Wilks’ Lambda treatment (p < 0.001), time (p < 0.001) and treatment x time effects (p < 0.001).
The Greenhouse-Geisser univariate treatment x time interaction is reported above. * represents p < 0.05 difference from baseline. a denotes a significant difference
from PLA. b denotes a significant difference from PWS. c denotes a significant difference from PWS + S
Table 8 Muscle and Liver enzymes and Markers of Catabolism
Variable Treatment Time (h) p-level
0 2
ALP PLA 79.8 ± 21.7 85.7 ± 27.5 0.70
(U/L) PWS 77.7 ± 31.1 82.3 ± 22.5
PWS + S 75.0 ± 19.2 82.2 ± 23.0
ALT PLA 29.5 ± 27.6 33.3 ± 32.9 0.26
(U/L) PWS 24.5 ± 11.0 28.0 ± 12.2
PWS + S 25.7 ± 11.7 27.1 ± 10.1
AST PLA 38.1 ± 60.6 44.9 ± 75.7 0.37
(U/L) PWS 24.9 ± 6.2 29.6 ± 7.1
PWS + S 25.3 ± 6.6 28.8 ± 6.5
CK PLA 713 ± 2354 836 ± 2786 0.33
(U/L) PWS 191 ± 104 231 ± 111
PWS + S 189 ± 85 223 ± 85
LDH PLA 182 ± 77 205 ± 115 0.55
(U/L) PWS 161 ± 18 187 ± 22
PWS + S 167 ± 26 192 ± 24
BUN PLA 15.9 ± 4.8 14.4 ± 4.1 0.013
(mg/dl) PWS 17.4 ± 4.7 15.1 ± 3.7*
PWS + S 16.4 ± 4.0 15.9 ± 3.5
Creatinine PLA 0.99 ± 0.14 1.05 ± 0.16 0.037
(mg/dl) PWS 1.09 ± 0.17 a,c 1.23 ± 0.17 *a
PWS + S 0.97 ± 0.14 1.11 ± 0.17 *a,b
BUN: Creatinine PLA 16.2 ± 5.9 13.9 ± 4.9 * <0.001
PWS 16.2 ± 5.0 12.3 ± 3.2 *a,c
PWS + S 17.1 ± 4.8 14.4 ± 3.4 *
Values are means ± standard deviations for alkaline phosphatase (ALP),
aspartate transaminase (AST), alanine transaminase (ALT), creatine kinase (CK),
lactate dehydrogenase (LDH), blood urea nitrogen (BUN), and creatinine.
MANOVA analysis revealed overall Wilks’ Lambda treatment (p < 0.001), time
(p < 0.001), and treatment x time (p < 0.001) effects. Greenhouse-Geisser uni-
variate p-levels of interaction (treatment x time) are reported above. * repre-
sents p < 0.05 difference from baseline. a denotes a significant difference from
PLA. b denotes a significant difference from PWS. c denotes a significant differ-
ence from PWS + S
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also evidence that Citrus aurantium ingestion can affect
memory [40, 41]. Therefore, it’s plausible that ingestion
of a PWS containing caffeine and/or p-synephrine could
affect mental focus and/or cognitive function prior to
and/or during exercise. In the present study, participants
ingesting the PWS’s indicated they felt more optimistic
about performance and more vigorous and energetic
after ingestion the PWS’s compared to the PLA treat-
ment. Additionally, there was evidence that ingestion of
the PWS and PWS + S consistently increased Word,
Color, and Word-Color scores from baseline and that
some of these changes were greater than PLA responses
after 1 or 2 h. However, it should be noted that partici-
pants started the PWS + S treatment with lower scores
prior to supplementation and the scores in the PWS + S
treatment did not exceed PLA or PWS responses at any
data point so these results should be interpreted with
caution. Further, the addition of 20 mg of p-synephrine
to the PWS supplement used in our study did not ap-
pear to provide additive benefit. Results are in agreement
with Hoffman et al. [71] who reported a significantly
greater feeling of energy and focus compared to placebo
after ingesting a supplement containing a PWS but
contrast those of Gonzales and associates [72] who re-
ported no significant difference in VAS ratings of energy
when ingesting a supplement containing caffeine, creat-
ine, β-alanine. However, the participants in that study
were administered the supplement 10-min before per-
forming resistance-exercise which may have limited re-
sults since it takes about an hour for caffeine levels in
the blood to peak after caffeine ingestion [1, 4].
Exercise performance
Numerous studies have evaluated the effects of ingesting
PWS’s and/or energy drinks containing a variety of nutri-
ents on exercise performance [1]. For example, Walsh and
colleagues [70] reported that ingestion of a PWS contain-
ing 2.05 g of an energy matrix (caffeine, taurine, glucuro-
nolactone) with amino acids significantly improved
perceptions of energy, decreased perceptions of fatigue, an
improved run time to exhaustion at 70% of VCO2 max.
Gonzalez et al. [72] reported that acute ingestion of a pre-
workout supplement containing caffeine, β-alanine, and
creatine significantly increased the number of repetitions
performed at 80% of 1RM as well as peak and mean power
of bench press. Additionally, Ratamess et al. [30] reported
that acute supplementation of PWS’s containing p-
synephrine (100 mg), p-synephrine (100 mg) and caffeine
(100 mg) increased the number of repetitions and lifting
volume (6 sets of squats for up to 10 repetitions at 80%
1RM) compared to control and placebo treatments. Dif-
ferences were more noted in the final 3 sets of exercise.
Further, mean power and lifting velocity was reported to
be higher for the caffeine and p-synephrine treatment
compared to control and placebo treatments. Conse-
quently, there is evidence that ingestion of caffeine and/or
p-synephrine prior to exercise may affect high intensity
exercise performance.
In the present study, no clear ergogenic benefit of PWS
or PWS+ S ingestion was observed. While participants in
the PWS+ S treatment tended to perform more total work
during the final set of bench press, no overall differences
were observed in bench press or leg press lifting volume.
Additionally, no differences were observed among treat-
ments in the Wingate Anaerobic Capacity cycling sprint
test. Therefore, while participants reported they had more
energy and were more optimistic about performance, it
did not result in statistically significant differences in
upper and lower body muscular endurance or sprint
capacity. Whether adding more p-synephrine to the PWS
or regular use of these PWS’s during training may yield
more definitive ergogenic benefit remains to be unclear.
Safety
One of the criticisms of use of energy drinks and/or
PWS’s containing caffeine and/or p-synephrine is that
they may increase heart, blood pressure, and/or prevalence
Table 9 Blood Lipid and Glucose Panel
Variable Treatment Time (h) p-level
0 2
Cholesterol PLA 170.6 ± 34.6 182.8 ± 35.1 0.006
(mg/dl) PWS 187.3 ± 46.6 a 180.2 ± 36.9
PWS + S 161.7 ± 29.8 a,b 174.0 ± 33.5 a
HDL-c PLA 54.9 ± 13.3 60.1 ± 16.0 0.57
(mg/dl) PWS 52.2 ± 13.9 58.9 ± 14.6
PWS + S 54.2 ± 16.2 60.1 ± 18.1
CHOL: HDL-c PLA 3.2 ± 0.9 b 3.2 ± 0.9 0.001
PWS 3.8 ± 1.3 a,c 3.2 ± 1.0 *
PWS + S 3.2 ± 1.0 b 3.1 ± 1.0
LDL-c PLA 104.3 ± 36.7 109.6 ± 41.2 0.55
(mg/dl) PWS 96.9 ± 31.9 104.5 ± 36.0
PWS + S 99.8 ± 41.2 104.6 ± 40.7
Triglycerides PLA 98.0 ± 58.6 89.3 ± 38.3 0.14
(mg/dl) PWS 109.5 ± 56.8 100.3 ± 47.5
PWS + S 88.3 ± 42.2 92.8 ± 54.6
Glucose PLA 90.2 ± 9.7 101.5 ± 14.4 * 0.03
(mg/dl) PWS 100.1 ± 16.0 a,c 114.4 ± 12.6 *a
PWS + S 90.4 ± 7.3 113.8 ± 15.0 *a
Values are means ± standard deviations for total cholesterol (CHOL), high
density lipoproteins (HDL-c), the CHOL: HDL ratio (CHOL: HDL-c), low density li-
poproteins (LDL-c), triglycerides and blood glucose. MANOVA analysis revealed
overall Wilks’ Lambda treatment (p < 0.001), time (p < 0.001), and treatment x
time (p < 0.001). Greenhouse-Geisser univariate p-levels of interaction (treat-
ment x time) are reported above. * represents p < 0.05 difference from base-
line. a denotes a significant difference from PLA. b denotes a significant
difference from PWS. c denotes a significant difference from PWS + S
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of arrhythmias [1, 73, 74]. In the present study, acute inges-
tion of PWS or PWS+ S did not significantly increased
heart rate, blood pressure, or effect resting ECG’s. Addition-
ally, although there were some expected changes in blood
markers in response to exercise (hemoconcentration) and/
or ingestion of maltodextrin, creatine, and caffeine contain-
ing PWS’s (i.e., evidence of increased creatinine, lipolysis,
and blood glucose release); values remained within normal
expected values for trained individuals undergoing intense
exercise [53–56] as well as within normal clinical ranges
[57]. In this regard, creatinine levels expectedly increased to
a greater degree in the PWS and PWS + S but these values
were small and well-within normal ranges for active indi-
viduals particularly when taking creatine [2, 6, 25, 53].
Moreover, while significant interactions were observed
among treatments in BUN and the ratio of BUN: Creatin-
ine, all values decreased suggesting less general whole body
catabolism. Additionally, while significant differences were
seen in total cholesterol among treatments, total cholesterol
did not significantly change from baseline in any treatment
and the CHOL: HDL-c ratio either was unchanged or
decreased suggesting reduced risk. Finally, while differences
were observed among treatments in pre- and post-exercise/
supplementation blood glucose values and blood glucose
was higher with PWS ingestion suggesting greater hepatic
glucose release (which would be beneficial during exercise);
no significant differences were observed between PWS and
PWS+ S treatments and all treatments and were within
normal expected exercise ranges [57]. We also did not
observe any adverse events related to the study that
required medical treatment or clinical findings that re-
quired medical referral. Consequently, ingestion of these
PWS’s prior to exercise did not appear to promote any
clinically relevant changes in these markers. These findings
support prior reports that ingestion of PWS’s and/or energy
drinks do not appear to pose undo health risk in apparently
healthy individuals [58, 59, 63, 75–78].
Conclusion
Within the limits of the present study, acute ingestion of
PWS and/or PWS + S prior to exercise appears to be well-
tolerated when consumed by young, healthy individuals.
The primary effects appear to be to increase resting energy
expenditure responses and improve perceptions about
readiness to perform and cognitive function with limited to
no effects on muscular endurance and no effects on anaer-
obic sprint capacity. The addition of 20 mg of p-synephrine
to the PWS yielded limited to no additive benefits. Whether
regular use of the PWS’s used in this study and/or higher
amounts of p-synephrine may promote greater benefits
remains to be determined. Given the widespread use of
PWS’s and energy drinks, additional study to examine the
safety and efficacy is warranted.
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